Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Parsons

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|August 1, 1989
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactamsW H Parsons, A A Patchett, M K Holloway, et al.
Journal of Medicinal Chemistry|August 1, 1989
(3-Amino-2-oxoalkyl)phosphonic acids and their analogues as novel inhibitors of D-alanine:D-alanine ligaseP K Chakravarty, W J Greenlee, W H Parsons, et al.
Biochemical and Biophysical Research Communications|November 30, 1983
Benzolactams. A new class of converting enzyme inhibitorsW H Parsons, J L Davidson, D Taub, et al.
Journal of Medicinal Chemistry|September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitorsA E Weber, T A Halgren, J J Doyle, et al.
Journal of Medicinal Chemistry|September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligaseW H Parsons, A A Patchett, H G Bull, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length studyM T Goulet, P J Sinclair, F Wong, et al.
Journal of Medicinal Chemistry|February 4, 1994
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibitionT Biftu, J J Acton, G D Berger, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|November 11, 1994
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivativesM M Ponpipom, N N Girotra, R L Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potentialM T Goulet, S R McAlpine, M J Staruch, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|August 1, 1989
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactamsW H Parsons, A A Patchett, M K Holloway, et al.
Journal of Medicinal Chemistry|August 1, 1989
(3-Amino-2-oxoalkyl)phosphonic acids and their analogues as novel inhibitors of D-alanine:D-alanine ligaseP K Chakravarty, W J Greenlee, W H Parsons, et al.
Biochemical and Biophysical Research Communications|November 30, 1983
Benzolactams. A new class of converting enzyme inhibitorsW H Parsons, J L Davidson, D Taub, et al.
Journal of Medicinal Chemistry|September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitorsA E Weber, T A Halgren, J J Doyle, et al.
Journal of Medicinal Chemistry|September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligaseW H Parsons, A A Patchett, H G Bull, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length studyM T Goulet, P J Sinclair, F Wong, et al.
Journal of Medicinal Chemistry|February 4, 1994
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibitionT Biftu, J J Acton, G D Berger, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|November 11, 1994
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivativesM M Ponpipom, N N Girotra, R L Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potentialM T Goulet, S R McAlpine, M J Staruch, et al.
Pageof 3